PIN8 COST EFFECTIVENESS OF THE MF59-ADJUVANTED INFLUENZA VACCINE IN FRANCE:THE “AT-RISK” ADULT POPULATION
J Chambers, K Tolley, J Piercy, S WaitVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65515-5
File:
PDF, 72 KB
english, 2007